High-resolution melting analysis for rapid screening of BRCA2 founder mutations in Southern Chinese breast cancer patients

Breast Cancer Research and Treatment

Volumn 122, Issue 2, 2010, Pages 605-607

  Kwong, Ava ^a,c,e   Ng, E K O ^a,b   Law, F B F ^b   Wong, L P ^b,e   To, M Y ^b   Cheung, M T ^b   Wong, H N ^a   Chan, V W ^a   Kurian, Allison ^c   West, D W ^c,d   Ford, J M ^c   Ma, E S K ^b,e  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b HONG KONG SANATORIUM AND HOSPITAL   (Hong Kong)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d North California Cancer Centre   (United States)

^e Hong Kong Hereditary Breast Cancer Family Registry   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; APOPTOSIS REGULATORY PROTEIN; BLID PROTEIN, HUMAN; BRCA2 PROTEIN, HUMAN;

ADULT; AGED; BREAST CANCER; CANCER PATIENT; CHINESE; CONTROLLED STUDY; FEMALE; FOUNDER EFFECT; GENE DELETION; GENE MUTATION; GENE SEQUENCE; GENETIC SCREENING; HUMAN; LETTER; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; ADOLESCENT; ASIAN CONTINENTAL ANCESTRY GROUP; BREAST TUMOR; CHINA; ETHNOLOGY; EXON; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; MUTATION; NUCLEOTIDE SEQUENCE; PREDICTIVE VALUE; PROCEDURES; TRANSITION TEMPERATURE; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; BRCA2 PROTEIN; BREAST NEOPLASMS; CHINA; DNA MUTATIONAL ANALYSIS; EXONS; FEMALE; FOUNDER EFFECT; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; HUMANS; MIDDLE AGED; MUTATION; PREDICTIVE VALUE OF TESTS; TRANSITION TEMPERATURE; YOUNG ADULT; APOPTOSIS REGULATORY PROTEINS;

EID: 77955665446     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-010-0882-3     Document Type: Letter

References (15)

1. Kwong A et al (2009) A BRCA2 founder mutation and seven novel deleterious BRCA mutations in southern Chinese women with breast and ovarian cancer. Breast Cancer Res Treat 117(3):683-686.
2. van der Stoep N et al (2009) Diagnostic guidelines for highresolution melting curve (HRM) analysis: an interlaboratory validation of BRCA1 mutation scanning using the 96-well LightScanner. Hum Mutat 30(6):899-909.
3. de Juan I et al (2009) High-resolution melting analysis for rapid screening of BRCA1 and BRCA2 Spanish mutations. Breast Cancer Res Treat 115(2):405-414.
4. Takano EA et al (2008) Rapid detection of carriers with BRCA1 and BRCA2 mutations using high resolution melting analysis. BMC Cancer 8:59.
5. Snell C et al (2008) BRCA1 promoter methylation in peripheral blood DNA of mutation negative familial breast cancer patients with a BRCA1 tumour phenotype. Breast Cancer Res 10(1):R12.
6. Kristensen LS et al (2008) Sensitive melting analysis after real time-methylation specific PCR (SMART-MSP): high-throughput and probe-free quantitative DNA methylation detection. Nucleic Acids Res 36(7):e42.
7. Krypuy M et al (2007) High resolution melting for mutation scanning of TP53 exons 5-8. BMC Cancer 7:168.
8. Wittwer CT et al (2003) High-resolution genotyping by amplicon melting analysis using LCGreen. Clin Chem 49(61):853-860.
9. Herrmann MG et al (2007) Expanded instrument comparison of amplicon DNA melting analysis for mutation scanning and genotyping. Clin Chem 53(8):1544-1548.
10. Erali M, Voelkerding KV, Wittwer CT (2008) High resolution melting applications for clinical laboratory medicine. Exp Mol Pathol 85(1):50-58.
11. Khoo US et al (2002) Recurrent BRCA1 and BRCA2 germline mutations in ovarian cancer: a founder mutation of BRCA1 identified in the Chinese population. Hum Mutat 19(3):307-308.
12. Chou LS, Lyon E, Wittwer CT (2005) A comparison of highresolution melting analysis with denaturing high-performance liquid chromatography for mutation scanning: cystic fibrosis transmembrane conductance regulator gene as a model. Am J Clin Pathol 124(3):330-338.
13. Tindall EA et al (2009) Assessing high-resolution melt curve analysis for accurate detection of gene variants in complex DNA fragments. Hum Mutat 30(6):876-883.
14. Oddoux C et al (1996) The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1%. Nat Genet 14(2):188-190.
15. FitzGerald MG et al (1996) Germ-line BRCA1 mutations in Jewish and non-Jewish women with early-onset breast cancer. N Engl J Med 334(3):143-149.